MedTrace Logo

Elacytarabine Mass Balance Study in Healthy Volunteers

NCT01783964 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2013-08-28

No results posted yet for this study

Summary

This study is performed to measure the quantity of i.v. applied elacytarabine that leave the body, by which route and how fast.

Conditions

  • Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects

Interventions

DRUG

[14C]-Elacytarabine

Single intravenous administration

Sponsors & Collaborators

  • Clavis Pharma

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-02-28
Completion
2013-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01783964 on ClinicalTrials.gov